TickerFacts.

SELLAS Life Sciences Group, Inc. (SLS): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$11.86M
Year ended 2016-12-31
2010-12-31: -$10.36M2011-12-31: -$14.72M2013-12-31: -$29.25M2014-12-31: -$42.93M2015-12-31: -$48.31M2016-12-31: -$11.86M-$11.86M
2010-12-31 Free Cash Flow (USD) 2016-12-31
Period endedFree Cash FlowChange YoYSource filing
2016-12-31-$11.86Mn/m2018-04-13, From 2016-01-01
2015-12-31-$48.31Mn/m2017-03-15, From 2015-01-01
2014-12-31-$42.93Mn/m2017-03-15, From 2014-01-01
2013-12-31-$29.25Mn/a2016-04-15, From 2013-01-01
No annual figure between 2011-12-31 and 2013-12-31.
2011-12-31-$14.72Mn/m2014-03-17, From 2011-01-01
2010-12-31-$10.36Mn/a2012-03-28, From 2010-01-01